GENERAL AMERICAN INVESTORS CO INC
Position in SPRY — ARS Pharmaceuticals, Inc.
CIK 40417
NEW YORK, NY
Position in SPRY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$9,075,698
+$3,236,652 QoQ
Shares Held
1,133,046
+55.8% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#17
of 209 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GENERAL AMERICAN INVESTORS CO INC holds $67,512,742 across 6 Biotechnology names. SPRY ranks #5 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,362 | $22,673,161 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
62,545 | $11,713,427 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
308,240 | $11,488,104 | |
| 4 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
1,716,193 | $10,709,044 | |
| 5 | SPRY |
ARS Pharmaceuticals, Inc.
This page
|
1,133,046 | $9,075,698 | |
| 6 | VALN |
Valneva SE
|
354,361 | $1,853,308 |
All Filings in SPRY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,075,698 | 1,133,046 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $5,839,046 | 727,154 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $6,523,522 | 559,959 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||